Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Merck
Farmers Insurance
Novartis
Healthtrust
McKesson
Dow
Chubb
Harvard Business School
Julphar

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,257,233

« Back to Dashboard

Summary for Patent: 6,257,233
Title: Dry powder dispersing apparatus and methods for their use
Abstract:The invention provides various apparatus and methods for aerosolizing a powdered medicament. In one exemplary embodiment, an apparatus includes a pressurization cylinder, and a piston which is slidable within the cylinder to pressurize a gas. A handle is coupled to the piston and is movable between an extended position and a home position to pressurize the gas. An aerosolizing mechanism is included and is configured to aerosolize a powdered medicament that is held within a receptacle with pressurized gas from the cylinder. A carriage assembly is included to receive the receptacle and to couple the receptacle to the aerosolizing mechanism. A first and a second interlock are operably engageable with the carriage assembly to prevent coupling of the receptacle with the aerosolization mechanism. The first interlock is released to allow movement of the carriage upon movement of the handle to the extended position. The second interlock remains engaged if the receptacle is only partially inserted into the carriage assembly.
Inventor(s): Burr; John D. (Redwood City, CA), Smith; Adrian E. (Belmont, CA), Hall; Randy K. (Mountain View, CA), Snyder; Herman (Belmont, CA), Schuler; Carlos (Cupertino, CA), Axford; George S. (San Mateo, CA), Ray; Charles (Foster City, CA)
Assignee: Inhale Therapeutic Systems (San Carlos, CA)
Application Number:09/312,434
Patent Claim Types:
see list of patent claims
Device; Use; Delivery;

Drugs Protected by US Patent 6,257,233

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Pfizer EXUBERA insulin recombinant human POWDER;INHALATION 021868-001 Jan 27, 2006 DISCN No No ➤ Sign Up ➤ Sign Up METHOD OF ADMINISTERING INSULIN VIA INHALATION ➤ Sign Up
Pfizer EXUBERA insulin recombinant human POWDER;INHALATION 021868-002 Jan 27, 2006 DISCN No No ➤ Sign Up ➤ Sign Up METHOD OF ADMINISTERING INSULIN VIA INHALATION ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 6,257,233

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,407,236 Adenosine A3 receptor modulators ➤ Sign Up
6,901,929 Dry powder dispersing apparatus and methods for their use ➤ Sign Up
8,161,969 Dry powder dispersing apparatus and methods for their use ➤ Sign Up
6,921,825 Adenosine A3 receptor modulators ➤ Sign Up
7,422,013 Dry powder dispersing apparatus and methods for their use ➤ Sign Up
7,470,698 Adenosine A3 receptor modulators ➤ Sign Up
7,271,171 Adenosine A.sub.3 receptor modulators ➤ Sign Up
6,448,253 Adenosine A3 receptor modulators ➤ Sign Up
6,546,929 Dry powder dispersing apparatus and methods for their use ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,257,233

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
New Zealand 509149 ➤ Sign Up
African Intellectual Property Organization (OAPI) 11692 ➤ Sign Up
Panama 8474901 ➤ Sign Up
Peru 06262000 ➤ Sign Up
Norway 20006167 ➤ Sign Up
New Zealand 508536 ➤ Sign Up
Norway 318078 ➤ Sign Up
Norway 20005508 ➤ Sign Up
Mexico PA03011958 ➤ Sign Up
Malaysia 135967 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
McKinsey
Cipla
Chinese Patent Office
Baxter
Queensland Health
US Army
Deloitte
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot